The Immunology and Biology of Brain Tumors

The Immunology and Biology of Brain Tumors

Immunotherapy has become a viable treatment modality for a variety of cancers (and referred to as Science Magazine’s “Breakthrough of the Year” in 2013, as well as ASCO’s “Advance of the Year” in both 2016 and 2017). This Special Issue is focused on the relevance of immunobiology in brain tumors, to...

Full description

Saved in:
Bibliographic Details
Sonstige:
Graner, Michael
Year of Publication:2021
Language:English
Physical Description:1 electronic resource (88 p.)
Tags: Add Tag
No Tags, Be the first to tag this record!
id 993546600204498
ctrlnum (CKB)5400000000044852
(oapen)https://directory.doabooks.org/handle/20.500.12854/76275
(EXLCZ)995400000000044852
collection bib_alma
record_format marc
spelling Graner, Michael edt
The Immunology and Biology of Brain Tumors
Basel, Switzerland MDPI - Multidisciplinary Digital Publishing Institute 2021
1 electronic resource (88 p.)
text txt rdacontent
computer c rdamedia
online resource cr rdacarrier
Immunotherapy has become a viable treatment modality for a variety of cancers (and referred to as Science Magazine’s “Breakthrough of the Year” in 2013, as well as ASCO’s “Advance of the Year” in both 2016 and 2017). This Special Issue is focused on the relevance of immunobiology in brain tumors, touching on elements of immune suppression, immune stimulation, and the immune microenvironment, with culminations in translational immunotherapy.
English
Medicine bicssc
vaccine therapy
oncoantigen
tumor associate antigen
tumor angiogenesis
high-grade glioma
pituitary neuroendocrine tumors
VEGF
Treg
TAM
PD-1
PD-L1
tumor microenvironment (TME)
glioblastoma multiforme (GBM)
GBM-associated macrophages (GAMs)
exosomes
oncomiR-21
STAT3 inhibitor
glioma
diffusion tensor imaging
generalized q-ball imaging
treatment-related effects
multiple resections
adrenal insufficiency
Addison’s disease
bevacizumab
cerebral radiation necrosis
craniopharyngioma
inflammation
checkpoint inhibitors
Interleukin-6
3-0365-0102-9
3-0365-0103-7
Graner, Michael oth
language English
format eBook
author2 Graner, Michael
author_facet Graner, Michael
author2_variant m g mg
author2_role Sonstige
title The Immunology and Biology of Brain Tumors
spellingShingle The Immunology and Biology of Brain Tumors
title_full The Immunology and Biology of Brain Tumors
title_fullStr The Immunology and Biology of Brain Tumors
title_full_unstemmed The Immunology and Biology of Brain Tumors
title_auth The Immunology and Biology of Brain Tumors
title_new The Immunology and Biology of Brain Tumors
title_sort the immunology and biology of brain tumors
publisher MDPI - Multidisciplinary Digital Publishing Institute
publishDate 2021
physical 1 electronic resource (88 p.)
isbn 3-0365-0102-9
3-0365-0103-7
illustrated Not Illustrated
work_keys_str_mv AT granermichael theimmunologyandbiologyofbraintumors
status_str n
ids_txt_mv (CKB)5400000000044852
(oapen)https://directory.doabooks.org/handle/20.500.12854/76275
(EXLCZ)995400000000044852
carrierType_str_mv cr
is_hierarchy_title The Immunology and Biology of Brain Tumors
author2_original_writing_str_mv noLinkedField
_version_ 1787548485524914176
fullrecord <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>02389nam-a2200649z--4500</leader><controlfield tag="001">993546600204498</controlfield><controlfield tag="005">20231214132837.0</controlfield><controlfield tag="006">m o d </controlfield><controlfield tag="007">cr|mn|---annan</controlfield><controlfield tag="008">202201s2021 xx |||||o ||| 0|eng d</controlfield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(CKB)5400000000044852</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(oapen)https://directory.doabooks.org/handle/20.500.12854/76275</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(EXLCZ)995400000000044852</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Graner, Michael</subfield><subfield code="4">edt</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">The Immunology and Biology of Brain Tumors</subfield></datafield><datafield tag="260" ind1=" " ind2=" "><subfield code="a">Basel, Switzerland</subfield><subfield code="b">MDPI - Multidisciplinary Digital Publishing Institute</subfield><subfield code="c">2021</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">1 electronic resource (88 p.)</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">text</subfield><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">computer</subfield><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">online resource</subfield><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">Immunotherapy has become a viable treatment modality for a variety of cancers (and referred to as Science Magazine’s “Breakthrough of the Year” in 2013, as well as ASCO’s “Advance of the Year” in both 2016 and 2017). This Special Issue is focused on the relevance of immunobiology in brain tumors, touching on elements of immune suppression, immune stimulation, and the immune microenvironment, with culminations in translational immunotherapy.</subfield></datafield><datafield tag="546" ind1=" " ind2=" "><subfield code="a">English</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Medicine</subfield><subfield code="2">bicssc</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">vaccine therapy</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">oncoantigen</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">tumor associate antigen</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">tumor angiogenesis</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">high-grade glioma</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">pituitary neuroendocrine tumors</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">VEGF</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">Treg</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">TAM</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">PD-1</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">PD-L1</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">tumor microenvironment (TME)</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">glioblastoma multiforme (GBM)</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">GBM-associated macrophages (GAMs)</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">exosomes</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">oncomiR-21</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">STAT3 inhibitor</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">glioma</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">diffusion tensor imaging</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">generalized q-ball imaging</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">treatment-related effects</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">multiple resections</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">adrenal insufficiency</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">Addison’s disease</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">bevacizumab</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">cerebral radiation necrosis</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">craniopharyngioma</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">inflammation</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">checkpoint inhibitors</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">Interleukin-6</subfield></datafield><datafield tag="776" ind1=" " ind2=" "><subfield code="z">3-0365-0102-9</subfield></datafield><datafield tag="776" ind1=" " ind2=" "><subfield code="z">3-0365-0103-7</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Graner, Michael</subfield><subfield code="4">oth</subfield></datafield><datafield tag="906" ind1=" " ind2=" "><subfield code="a">BOOK</subfield></datafield><datafield tag="ADM" ind1=" " ind2=" "><subfield code="b">2023-12-15 05:33:23 Europe/Vienna</subfield><subfield code="f">system</subfield><subfield code="c">marc21</subfield><subfield code="a">2022-04-04 09:22:53 Europe/Vienna</subfield><subfield code="g">false</subfield></datafield><datafield tag="AVE" ind1=" " ind2=" "><subfield code="i">DOAB Directory of Open Access Books</subfield><subfield code="P">DOAB Directory of Open Access Books</subfield><subfield code="x">https://eu02.alma.exlibrisgroup.com/view/uresolver/43ACC_OEAW/openurl?u.ignore_date_coverage=true&amp;portfolio_pid=5338242620004498&amp;Force_direct=true</subfield><subfield code="Z">5338242620004498</subfield><subfield code="b">Available</subfield><subfield code="8">5338242620004498</subfield></datafield></record></collection>

Similar Items